Medtronic plc (MDT) Earnings Call Analysis
NYSE · Healthcare · Medical Devices
Earnings Reports
-
Medtronic (MDT) Q4 2026: CAS Revenue Surges 78%, Fueling Durable Innovation-Led Growth
June 03, 2026
-
Medtronic (MDT) Q3 2026: Cardiovascular Jumps 11%, Pipeline Broadens Margin Pathways
February 23, 2026
-
Medtronic (MDT) Q2 2026: Cardiac Ablation Grows 71%, Igniting Multi-Year Revenue Acceleration
November 18, 2025
-
Medtronic (MDT) Q1 2026: Cardiac Ablation Solutions Surge 50%, Setting Up Multi-Year Growth Cycle
August 19, 2025
-
Medtronic (MDT) Q4 2025: Diabetes Spin-Off and Durable Growth Reshape Portfolio for Higher Margins
June 10, 2025